Lupitidine
 | |
| Systematic (IUPAC) name | |
|---|---|
|
2-[2-[[5-(2-Aminopropan-2-yl)furan-2-yl]methylsulfanyl]ethylamino]-5-[(6-methylpyridin-3-yl)methyl]-1H-pyrimidin-6-one | |
| Identifiers | |
| CAS Number | 83903-06-4 |
| ATC code | None |
| PubChem | CID 51670 |
| ChemSpider | 3577726 |
| UNII |
WF028DWK9N  |
| KEGG | D04794 |
| Chemical data | |
| Formula | C21H27N5O2S |
| Molar mass | 413.54 g/mol |
| |
Lupitidine (INN) (code name SKF-93479), or lupitidine hydrochloride (USAN), is a long-acting H2 receptor antagonist[1] developed by Smith, Kline & French and described as an antiulcerogenic that was never marketed.[2] It was shown to inhibit nocturnal gastric acid secretion[3] and, in experiments on rodents, produced diffuse neuroendocrine cell hyperplasia and an increase in multifocal glandular hyperplasia due to hypergastrinemia resulting from the pharmacological suppression of gastric acid secretion.[4]
Synthesis[5]
References
- ↑ Franzén, L; Ghassemifar, R; Malcherek, P (July 1991). "Experimental Mast Cell Activation Improves Connective Tissue Repair in the Perforated Rat Mesentery". Agents and Actions 33 (3–4): 371–7. PMID 1683107.
- ↑ J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 745–. ISBN 978-1-4757-2085-3.
- ↑ Dammann, H.G.; Muller, P.; Simon, B. (January 1982). "Inhibition of Nocturnal Acid Secretion by H2-Receptor-Antagonist SKF 93479". The Lancet 319 (8265): 224. doi:10.1016/S0140-6736(82)90788-7.
- ↑ Betton, GR; Dormer, CS; Wells, T; Pert, P; Price, CA; Buckley, P (1 February 1988). "Gastric ECL-Cell Hyperplasia and Carcinoids in Rodents Following Chronic Administration of H2-antagonists SK&F 93479 and Oxmetidine and Omeprazole". Toxicologic Pathology 16 (2): 288–298. doi:10.1177/019262338801600222. PMID 2903544.
- ↑ Lam, B. L.; Pridgen, L. N.; 1982, U.S. Patent 4,352,933
| ||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Sunday, January 31, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.